About Trimax Bio Sciences Private Limited
Data last updated: 14 December 2025
Trimax Bio Sciences Private Limited is a private limited company based in Tirumalagiri, Telangana, India. It specialises in api manufacturers, a part of the broader pharmaceuticals sector. Incorporated on 11 May 2010, the company has been in operation for over 16 years.
Registered with ROC Hyderabad under CIN U24297AP2010PTC068376.
Capital: an authorised share capital of ₹50 Cr and a paid-up capital of ₹36 Cr. It is led by directors including Chebrolu Murali Krishna and Swati Sinha.
Last AGM: 21 September 2024. Financial statements filed for year ended 31 March 2024. Office: Tirumalagiri, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹29.26 Cr, a decline of 49% compared to the previous year.
The company has a workforce of approximately 113 employees as per the latest available data.
The company is associated with 1 brand - Trimax Bio Sciences. As per MCA filings, the company has open charges of ₹29 Cr and satisfied charges of ₹33.81 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website trimaxbiosciences.com.
-
Email**************
-
Telephone**************
-
Website**************
-
Social Media**************
-
Registered Address229/1 & 90 2Nd Floor, Kalyans Tulsiram Chambers Madinaguda, Tirumalagiri, Telangana, India – 500049
-
IndustryPharma, API Manufacturers
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Trimax Bio Sciences Private Limited
Trimax Bio Sciences Private Limited has one previous CIN (Corporate Identification Number): U24297AP2010PTC068376. The current CIN is U24297TG2010PTC068376, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24297TG2010PTC068376 | Current |
| U24297AP2010PTC068376 | Previous |
Associated Brands with Trimax Bio Sciences Private Limited
Trimax Bio Sciences Private Limited operates one associated brand: Trimax Bio sciences. These brands represent Trimax Bio Sciences Private Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Non-infringing pharmaceutical research and healthcare products are developed. | trimaxbiosciences.com |
Competitors & Alternatives of Trimax Bio Sciences Private Limited
Brands and companies operating in the same space as Trimax Bio Sciences Private Limited include Inventys, Viyash, Blue Jet Healthcare and 6 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Inventys
|
Actives, advanced intermediates, and specialty chemicals are custom manufactured. | Mumbai, India, India | 2005 |
Viyash
|
APIs and intermediates are manufactured by Viyash as a CDMO. | Hyderabad, India, India | 2019 |
Blue Jet Healthcare
|
CDMO focused on manufacturing, supplier, and development of intermediates & APIs | Mumbai, India, India | 1969 |
Ami organics
|
Advanced API intermediates are manufactured for pharmaceutical use. | Surat, India, India | 2007 |
Aparna Pharmaceuticals
|
API intermediates are manufactured by Aparna Pharmaceuticals as a CDMO. | Hyderabad, India, India | 2008 |
HuiSheng Biotech Pharmaceutical
|
APIs, intermediates, and finished dosage forms are manufactured. | Hangzhou, China, China | 2004 |
DUDE CHEM
|
CDMO focused on manufacturing of APIs and intermediates | Berlin, Germany, Germany | 2019 |
Enanti Labs
|
Enanti Labs produces pharmaceutical intermediates and APIs in India with quality focus. | Hyderabad, India, India | 2007 |
Hindys Lab
|
Manufactures and exports pharmaceutical intermediates for global markets. | Hyderabad, India, India | 2007 |
Business Activity of Trimax Bio Sciences Private Limited
Trimax Bio Sciences Private Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | ********* |
Board of Directors of Trimax Bio Sciences Private Limited
Trimax Bio Sciences Private Limited is currently managed by 7 directors, with 11 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Chebrolu Murali Krishna
Also directs:
Zenith Peb Solutions Private Limited, Rythumithra Agrimarts Private Limited, Raichur Cold Storage Private Limited and 1 more
|
Director | 11 May 2010 | 16 Years 1 Months | Current |
| Swati Sinha | Director | 09 Jan 2024 | 2 Years 6 Months | Current |
|
Janardhana Reddy Yeddula
Also directs:
Sigachi Industries Limited, Virupaksha Organics Limited
|
Director | 07 Mar 2025 | 1 Years 4 Months | Current |
|
Dhanalakshmi Guntaka
Also directs:
Sigachi Industries Limited, Arunjyoti Bio Ventures Limited, B.N. Rathi Securities Limited and 2 more
|
Director | 09 Jan 2024 | 2 Years 6 Months | Current |
| Amit Raj Sinha | Additional Director | 09 Jan 2024 | 2 Years 6 Months | Current |
|
Nageswara Rao Karusala
Also directs:
Skytin Labs Private Limited
|
Director | 11 May 2010 | 16 Years 1 Months | Current |
Financials of Trimax Bio Sciences Private Limited FY 2024 filings available
Trimax Bio Sciences Private Limited reported revenue of ₹29.26 Cr (down 49% YoY) for FY 2025. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue from Operations | ***** | ***** | ***** | ***** | ***** |
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Other Income | ***** | ***** | ***** | ***** | ***** |
| Total Revenue | ***** | ***** | ***** | ***** | ***** |
| Expenses | |||||
| Total Expenses | ***** | ***** | ***** | ***** | ***** |
| Raw Material Cost | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory FG | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory WIP | ***** | ***** | ***** | ***** | ***** |
| Purchase of Traded Goods | ***** | ***** | ***** | ***** | ***** |
| Employee Cost | ***** | ***** | ***** | ***** | ***** |
| Managerial Remuneration | ***** | ***** | ***** | ***** | ***** |
| Audit Fees | ***** | ***** | ***** | ***** | ***** |
| Insurance | ***** | ***** | ***** | ***** | ***** |
| Power & Fuel | ***** | ***** | ***** | ***** | ***** |
| Interest | ***** | ***** | ***** | ***** | ***** |
| Depreciation | ***** | ***** | ***** | ***** | ***** |
| Other Expenses | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| EBITDA (Operating Profit) | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| Exceptional Items | ***** | ***** | ***** | ***** | ***** |
| Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Exceptional & Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Tax & Net Profit | |||||
| Tax Expense | ***** | ***** | ***** | ***** | ***** |
| Current Tax | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax | ***** | ***** | ***** | ***** | ***** |
| Profit from Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Tax on Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Profit | ***** | ***** | ***** | ***** | ***** |
| Net Margin % | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Shareholders' Funds | |||||
| Total Shareholders' Funds | ***** | ***** | ***** | ***** | ***** |
| Equity Capital | ***** | ***** | ***** | ***** | ***** |
| Reserves & Surplus | ***** | ***** | ***** | ***** | ***** |
| Money Against Warrants | ***** | ***** | ***** | ***** | ***** |
| Other Equity | ***** | ***** | ***** | ***** | ***** |
| Non-Current Liabilities | |||||
| Total Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Liabilities | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Current Liabilities | |||||
| Total Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Trade Payables | ***** | ***** | ***** | ***** | ***** |
| Other Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Total Equity & Liabilities | ***** | ***** | ***** | ***** | ***** |
| Non-Current Assets | |||||
| Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Tangible Assets | ***** | ***** | ***** | ***** | ***** |
| Intangible Assets | ***** | ***** | ***** | ***** | ***** |
| Capital WIP | ***** | ***** | ***** | ***** | ***** |
| Intangibles Under Dev | ***** | ***** | ***** | ***** | ***** |
| Investments | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Assets | ***** | ***** | ***** | ***** | ***** |
| LT Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Assets | |||||
| Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Investments | ***** | ***** | ***** | ***** | ***** |
| Inventories | ***** | ***** | ***** | ***** | ***** |
| Trade Receivables | ***** | ***** | ***** | ***** | ***** |
| Cash & Bank Balance | ***** | ***** | ***** | ***** | ***** |
| ST Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Current Assets | ***** | ***** | ***** | ***** | ***** |
| Total Assets | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Cash from Operating Activities (CFO) | |||||
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Non-Cash Adjustments | ***** | ***** | ***** | ***** | ***** |
| + Interest Expense | ***** | ***** | ***** | ***** | ***** |
| + Depreciation | ***** | ***** | ***** | ***** | ***** |
| +/- Unrealized Forex | ***** | ***** | ***** | ***** | ***** |
| - Dividend Income | ***** | ***** | ***** | ***** | ***** |
| - Interest Income | ***** | ***** | ***** | ***** | ***** |
| +/- Other Non-Cash Items | ***** | ***** | ***** | ***** | ***** |
| Changes in Working Capital | ***** | ***** | ***** | ***** | ***** |
| +/- Inventory | ***** | ***** | ***** | ***** | ***** |
| +/- Debtors | ***** | ***** | ***** | ***** | ***** |
| +/- Creditors | ***** | ***** | ***** | ***** | ***** |
| Reconciliation Adjustments | ***** | ***** | ***** | ***** | ***** |
| Cash Generated from Operations | ***** | ***** | ***** | ***** | ***** |
| Income Taxes Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFO (Cash from Operations) | ***** | ***** | ***** | ***** | ***** |
| Cash from Investing Activities (CFI) | |||||
| Acquisitions & Disposals | ***** | ***** | ***** | ***** | ***** |
| Disposal of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Acquisition of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Capex | ***** | ***** | ***** | ***** | ***** |
| Purchase of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Sale of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Other Investing Cash Flows | ***** | ***** | ***** | ***** | ***** |
| Net CFI (Cash from Investing) | ***** | ***** | ***** | ***** | ***** |
| Cash from Financing Activities (CFF) | |||||
| Equity Issuance | ***** | ***** | ***** | ***** | ***** |
| Debt Raised | ***** | ***** | ***** | ***** | ***** |
| Debt Repaid | ***** | ***** | ***** | ***** | ***** |
| Dividends Paid | ***** | ***** | ***** | ***** | ***** |
| Interest Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFF (Cash from Financing) | ***** | ***** | ***** | ***** | ***** |
| Net Cash Position | |||||
| Net Change in Cash (Pre-Forex) | ***** | ***** | ***** | ***** | ***** |
| Closing Cash & Equivalents | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Liquidity | |||||
| Current Ratio | ***** | ***** | ***** | ***** | ***** |
| Quick Ratio | ***** | ***** | ***** | ***** | ***** |
| Cash Ratio | ***** | ***** | ***** | ***** | ***** |
| Efficiency | |||||
| Inventory Days | ***** | ***** | ***** | ***** | ***** |
| Debtor Days | ***** | ***** | ***** | ***** | ***** |
| Creditor Days | ***** | ***** | ***** | ***** | ***** |
| Cash Conversion Cycle | ***** | ***** | ***** | ***** | ***** |
| Asset Turnover | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| Net Profit Margin % | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| ROE % | ***** | ***** | ***** | ***** | ***** |
| ROCE % | ***** | ***** | ***** | ***** | ***** |
| Net Worth Margin % | ***** | ***** | ***** | ***** | ***** |
| Growth | |||||
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Leverage | |||||
| Equity Multiplier | ***** | ***** | ***** | ***** | ***** |
| Debt / EBITDA | ***** | ***** | ***** | ***** | ***** |
| Solvency | |||||
| D/E Ratio | ***** | ***** | ***** | ***** | ***** |
| ICR | ***** | ***** | ***** | ***** | ***** |
Consolidated Statements
Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.
Charges & Borrowings of Trimax Bio Sciences Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 02 Dec 2024 | Others | ₹29 Cr | Open |
| 28 Mar 2019 | Others | ₹4 Cr | Satisfied |
| 28 Mar 2019 | Others | ₹7.5 Cr | Satisfied |
| 29 Mar 2012 | Others | ₹22.31 Cr | Satisfied |
Total charge records: 4 View all charges
Employees and EPFO Compliance at Trimax Bio Sciences Private Limited
View historical data on people associated with Trimax Bio Sciences Private Limited, including employment history and EPFO contributions.
Employee Count & EPFO Data of Trimax Bio Sciences Private Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Trimax Bio Sciences Private Limited
GSTIN & GST Filing Data of Trimax Bio Sciences Private Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Trimax Bio Sciences Private Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Trimax Bio Sciences Private Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Trimax Bio Sciences Private Limited
MSME Payment Delays by Trimax Bio Sciences Private Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Trimax Bio Sciences Private Limited
Subsidiaries & Group Companies of Trimax Bio Sciences Private Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Trimax Bio Sciences Private Limited with ownership details.
MCA Filings & Documents of Trimax Bio Sciences Private Limited
MCA Filings & Documents of Trimax Bio Sciences Private Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Trimax Bio Sciences Private Limited
Recent News on Trimax Bio Sciences Private Limited
Frequently Asked Questions about Trimax Bio Sciences Private Limited
Trimax Bio Sciences Private Limited is an active private limited company in the pharma sector based in Tirumalagiri, Telangana, India. It was incorporated on 11 May 2010 (16+ years old) and is registered under CIN U24297TG2010PTC068376. The company has 113 employees.
Trimax Bio Sciences Private Limited reported revenue of ₹29.26 Cr for FY 2025 (down 49.00% YoY).
The current directors of Trimax Bio Sciences Private Limited are:
The primary industry of Trimax Bio Sciences Private Limited is pharma. The company specifically operates in api manufacturers. The company is currently active in this sector.
Trimax Bio Sciences Private Limited can be reached at the registered office: 2291 & 90 2Nd Floor, Kalyans Tulsiram Chambers Madinaguda, Tirumalagiri, Telangana, India – 500049, or through the website trimaxbiosciences.com.
The authorised capital is ₹50 Cr, and the paid-up capital is ₹36 Cr.